Australia had imposed very strict travel restrictions on people travelling in and out of the country.
Novavax and its partner the Serum Institute say their request for the COVID-19 vaccine to the UN health agency is based on a previous submission to Indian regulators.
So far it means, under the new rules from October 4, Indian travellers must take a COVID test three days before departure and book in advance for two COVID tests to be taken upon arrival in England.
The Pune-based pharmaceutical company has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month.
Biocon and Serum Institute come together with strategic alliance to increase vaccine access for developing countries
As part of the deal, the BBL has offered 15% stake to SILS at a post money valuation of $4.9 billion in exchange for committed access to 100 million doses of vaccines per annul for 15 years.
Research and manufacturing infrastructure will also be leveraged by this partnership for opportunities in infectious diseases,” Shaw said.
The Union Health Ministry has recently placed a purchase order with SII for 54 lakh doses of IPV vaccine.
Serum Institute of India has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month.
In a production plan submitted to the Centre in May, SII's director had communicated that the production of Covishield would be ramped up to 10 crore each in August and September, sources had said.
Serum Institute of India (SII) has bought 50 per cent stake in Schott Kaisha to become Schott's joint venture partner and secure pharma packaging supply, the statement said.
Fighting COVID: Centre allocates Rs 267.35 crore to Kerala, allows purchasing of 10 lakh Covishield doses
The Centre had earlier allowed states and private hospitals to procure 50 per cent of the vaccines following demands for a decentralisation of the process.
COVID vaccine export ban 'very bad' move; son warned not to speak against it: SII's Cyrus Poonawalla
Over 150 countries are dependent on the SII for vaccines and are blaming the company for stopping the supply during a crucial period, Cyrus Poonawalla said.
No need to mix two COVID jabs: Serum Institute chairman Poonawalla against using cocktail of vaccines
The efficacy of this approach has not been proven in field trials involving thousands of participants, he said.
Had to fall at bureaucrats' feet 50 years ago, but licence raj came down under Modi govt: Poonawalla
Licence raj culture has diminished, which has resulted in quick launch of the coronavirus vaccine, Serum Institute of India chairman Cyrus Poonawalla said.
J&J has tied up with Hyderabad-based Biological E for the global supply chain network, hoping to supply its Covid-19 vaccine Janssen through extensive collaborations and partnerships.